30/12/2013 Journal
Date of Journal: 30/12/2013
| Guernsey Patent Application Number | Date of Application in Bailiwick | Patent Title | Field of Invention | Registered Proprietor | Overseas Registration, Jurisdiction, Number & Link to Web | Bailiwick Registered Agent | Supporting Documents |
|---|---|---|---|---|---|---|---|
| 696 | 02/12/2013 | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors | C07D 401/14, A61K 31/4439, A61P 35/00, C07D 401/04 | Pfizer Inc. | The European Patent Office EP1784396 Intellectual Property Office of The European Patent Office | 1025 |  696 [7Mb] |
| 697 | 02/12/2013 | Therapeutic formulation for administering tolterodine with controlled release | A61K 9/22, A61K 9/52, A61K 9/70, A61K 31/135, A61P 13/10 | Pfizer Health AB | The European Patent Office EP1039882 Intellectual Property Office of The European Patent Office | 1025 | 697 [804kb] |
| 698 | 02/12/2013 | Tricyclic compounds and their use as glucocorticoid receptor modulators | C07D 213/75, A61K 31/44, A61P 1/00, A61P 11/06, A61P 19/02, A61P 25/28, A61P 29/00 | Pfizer Products Inc. | The European Patent Office EP2114888 Intellectual Property Office of The European Patent Office | 1025 | 698 [2Mb] |
| 699 | 02/12/2013 | Pharmaceutical composition 271 | A61K 9/48, A61K 9/14, A61K 31/4184, C07D 235/06 | A) Astrazeneca AB B) Array Biopharma, Inc. | The European Patent Office EP2271321 Intellectual Property Office of The European Patent Office | 1025 | 699 [1Mb] |
| 700 | 04/12/2013 | 3-aminocyclopentanecarboxamides as chemokine receptor modulators | C07D 487/08, A61K 31/407, A61P 29/02, A61P 35/00 | Pfizer Inc | The European Patent Office EP2370442 Intellectual Property Office of The European Patent Office | 1025 | 700 [22Mb] |
| 707 | 16/12/2013 | A method of laying a floor covering | A47G 27/04, C09D 5/38, E04F 15/02 | !OBAC Limited | The European Patent Office EP1768527 Intellectual Property Office of The European Patent Office | 1025 | 707 [982kb] |
